Abstract:Background: Although a larger number of antiepileptic drugs became available in the last decades, epilepsy remains drug-resistant in approximately a third of patients. Ketogenic diet (KD), first proposed at the beginning of the last century, is complex and has anticonvulsant effects, yet not completely understood. Over the last decades, different types of ketogenic diets (KDs) have been developed, namely classical KD and modified Atkins diet (MAD). They offer an effective alternative for children and adults with drug-resistant epilepsies. Methods: We review several papers on KDs as an adjunctive treatment of refractory epilepsy of children and adults, discussing its efficacy and adverse events. Because of the heterogenous, uncontrolled nature of the studies, we analyzed all studies individually, without a meta-analysis. Results: KDs may be considered first choice treatment in some specific metabolic conditions, such as glucosetransporter type 1 and pyruvate dehydrogenase deficiencies, and mitochondrial complex I defects. Preliminary findings indicate that KDs may be specifically effective in some epileptic syndromes, such as West syndrome, severe myoclonic epilepsy of infancy, myoclonic-astatic epilepsy, febrile infection related epileptic syndrome, and drug-resistant idiopathic generalized epilepsies or refractory status epilepticus. Short term adverse events are usually mild in both children and adults, including gastrointestinal symptoms, hyperlipidemia, and hypercalciuria; potential long term adverse effects include nephrolitiasis, decreased bone density, and liver steatosis. Possible atherosclerotic effects remain a concern. Patients on KDs should be carefully monitored in specialized centers during initiation, maintenance and withdrawal periods, in order to minimize such adverse events, and to improve compliance. Although the majority of KD trials on children and adults with drug-resistant epilepsies are openlabel, uncontrolled studies based on small samples, an increasing number of randomized controlled trials have provided better quality evidence on its efficacy in recent years. Conclusion: There is a need for future randomized clinical trials aimed to confirm the efficacy of KDs in specific epileptic syndromes, and to provide further information about some practical unsolved problems, i.e. for how long KD treatment should be continued.

Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations

Therapeutic potential of the ketogenic diet: A metabolic switch with implications for neurological disorders, the gut-brain axis, and cardiovascular diseases

The impact of ketogenic diet on some metabolic and non‐metabolic diseases: Evidence from human and animal model experiments

Ketogenic Diet: A New Light Shining on Old but Gold Biochemistry

Ketogenic diet: A nutritional remedy for some metabolic disorders

[Ketogenic Diet and its Evidence-Based Therapeutic Implementation in Endocrine Diseases]

Ketogenic Dietary Therapy in Adult Status Epilepticus: Current Progress and Clinical Application

Ketogenic Diet and Multiple Health Outcomes: An Umbrella Review of Meta-Analysis

Efficacy and Safety of the Ketogenic Diet for Mitochondrial Disease With Epilepsy: A Prospective, Open-labeled, Controlled Study

Advance of mechanism of ketogenic diet in refractory childhood epilepsy

The Ketogenic Diet for the Treatment of Epilepsy: A Challenge for Nutritional Neuroscientists

Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases

Therapeutic Success of the Ketogenic Diet As A Treatment Option for Epilepsy: A Meta-Analysis

Ketogenic Diet: A Dietary Intervention via Gut Microbiome Modulation for the Treatment of Neurological and Nutritional Disorders (a Narrative Review)

Therapeutic Use of the Ketogenic Diet in Refractory Epilepsy: What We Know and What Still Needs to Be Learned

Ketogenic Diet: A Review of Composition Diversity, Mechanism of Action and Clinical Application

Ketogenic Diets in the Treatment of Epilepsy

The Therapeutic Role of Ketogenic Diet in Neurological Disorders

Neuroprotection by the Ketogenic Diet: Evidence and Controversies

Metabolic epilepsies amenable to ketogenic therapies: Indications, contraindications, and underlying mechanisms

The Unconventional Effects of the Ketogenic Diet (KD) in Preclinical Epilepsy